IDIBELL on the media
Women with resistant OCD have a worse answer to deep-brain stimulation
The IDIBELL and Bellvitge University Hospital Psychiatry and Mental Health research group has published an article that indicates that men have a better long-term prognosis in treatment with deep brain stimulation (DBS) for Obsessive Compulsive Disorder (OCD).
IDIBELL celebrates a new edition of the Accelerator Meeting Point
In this event, innovative projects from the biotech and biomedical sector looking for market transfer resources will be presented.
The +ACTIU project brings together professionals and citizens to discuss the design of healthier cities
This is a research project focused on community health that seeks to promote citizen participation in the design and co-creation of active and healthy cities
The integrity of the blood-brain barrier depends on a protein that is altered in some neurodegenerative diseases
A study led by the Bellvitge Biomedical Research Institute (IBIDELL) and the University of Barcelona reveals that the TDP-43 protein is essential for forming a stable and mature blood vessel network in the central nervous system.
A new tool based on Artificial Intelligence will improve brain tumour diagnosis
This study demonstrates the potential of the DISCERN application to aid medical decisions for the diagnosis of brain tumours using standard MRI.
8M: Every 8 minutes a woman dies of cardiovascular disease
This 8M, IDIBELL wants to focus on cardiovascular diseases in women
The Spanish Association Against Cancer in Barcelona finances two IDIBELL projects with 445,000 euros
Two IDIBELL projects, one led by Dr. Marta Crous and the other by Dr. Bárbara Rivera, have been selected to receive funding from the Association Against Cancer in Barcelona.
March 4, International Human Papillomavirus Awareness Day
Worldwide, more than half a million cancers are caused by HPV. HPV is the cause of all cervical cancers and also some cancers of the vulva, penis, vagina, anus and oropharynx.
